Viveve Medical, Inc.

Equities

VIVE

US92852W5013

Advanced Medical Equipment & Technology

Market Closed - OTC Markets Other stock markets 02:20:42 2024-04-26 pm EDT			5-day change	1st Jan Change
0.0002 ^USD	-33.33%		-33.33%	0.00%

2023	InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	CI
2023	Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	CI

Viveve Medical, Inc. announced that it expects to receive $0.014675 million in funding

October 13, 2022

Viveve Medical, Inc. announced that it will receive $14,675 in funding on October 14, 2022. The company will issue common shares in the transaction. The company will issue securities pursuant to exemption provided under Regulation D.

Latest news about Viveve Medical, Inc.

InMode Ltd. acquired Intellectual Property Assets of Viveve Medical Inc.	23-07-24	CI
Viveve Medical, Inc.(OTCPK:VIVE) dropped from S&P TMI Index	23-01-23	CI
Viveve Medical, Inc.(OTCPK:VIVE) dropped from NASDAQ Composite Index	23-01-18	CI
Sector Update: Health Care Stocks Finishing Near Intra-Day Lows	23-01-17	MT
Sector Update: Health Care Stocks Sputtering in Tuesday Trading	23-01-17	MT
Top Midday Decliners	23-01-17	MT
Sector Update: Health Care	23-01-17	MT
Sector Update: Health Care Stocks Flat to Lower Premarket Tuesday	23-01-17	MT
Sector Update: Health Care	23-01-17	MT
Investors Digest More Big Bank Earnings, Weighing on US Equity Futures	23-01-17	MT
Weak China GDP Data Weigh on Exchange-Traded Funds, Equity Futures Premarket Tuesday	23-01-17	MT
Top Premarket Decliners	23-01-17	MT
Viveve Medical Fails to Meet Primary Endpoint in Stress Urinary Incontinence Study; Unveils Cut in Workforce; Expects Delisting From Nasdaq	23-01-17	MT
Viveve Announces Topline Results from Pivotal U.S. PURSUIT Trial for Treating Female Stress Urinary Incontinence	23-01-17	CI
Viveve Medical to Seek Strategic Alternatives	23-01-16	CI
Viveve Medical, Inc. Announces Completion of Pivotal US Pursuit Trial for Female Stress Urinary Incontinence	22-12-15	CI
Transcript : Viveve Medical, Inc., Q3 2022 Earnings Call, Nov 10, 2022	22-11-10
Viveve Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-10	CI
Earnings Flash (VIVE) VIVEVE MEDICAL Posts Q3 Revenue $1.7M	22-11-10	MT
Viveve Medical, Inc. announced that it has received $0.014675 million in funding	22-10-26	CI
Viveve Medical, Inc. announced that it expects to receive $0.014675 million in funding	22-10-13	CI
Viveve Medical, Inc. Announces Notice of Allowance for Second U.S. Method Patent for Treating Female Stress Urinary Incontinence	22-10-04	CI
Viveve Medical, Inc. Launches Rebranding Initiative to Reflect Focus on Treatment of Female Stress Urinary Incontinence in Anticipation of U.S. Pivotal Pursuit Trial Readout	22-09-27	CI
Transcript : Viveve Medical, Inc., Q2 2022 Earnings Call, Aug 11, 2022	22-08-11
Viveve Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI

Chart Viveve Medical, Inc.

Duration

Period

More charts

Company Profile

Viveve Medical, Inc. designs, develops, manufactures and markets a platform medical technology, Cryogen-cooled Monopolar RadioFrequency (CMRF). The Companyâs CMRF technology is delivered through a radiofrequency generator, handpiece and treatment tip, which collectively, is referred to as the Viveve System. The Viveve System is marketed for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence (SUI). In the United States, the Viveve System is indicated for use in general surgical procedures for electrocoagulation and hemostasis. The Viveve System is cleared for marketing in approximately 48 countries throughout the world, including North America, Asia Pacific, Europe, the Middle East and Latin America countries. The Companyâs wholly owned subsidiaries include Viveve, Inc. and Viveve BV.

Sector

Advanced Medical Equipment & Technology

More about the company

	1st Jan change	Capi.
VIVEVE MEDICAL, INC.	0.00%	2.14K
THERMO FISHER SCIENTIFIC	+8.07%	219B
DANAHER CORPORATION	+6.59%	183B
INTUITIVE SURGICAL, INC.	+11.26%	133B
BOSTON SCIENTIFIC CORPORATION	+26.57%	108B
EDWARDS LIFESCIENCES CORPORATION	+13.35%	52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.62%	48.2B
AGILENT TECHNOLOGIES, INC.	-0.93%	40.37B
GE HEALTHCARE TECHNOLOGIES INC.	+11.54%	39.35B
RESMED, INC.	+26.76%	32.03B

Other Advanced Medical Equipment & Technology